Manifestations of an overdose of VARIZIG administered intramuscularly are expected to be pain and tenderness at the injection site.
- Individuals known to have anaphylactic or severe systemic (hypersensitivity) reactions to human immune globulin preparations should not receive VARIZIG.
- IgA-deficient patients with antibodies against IgA and a history of hypersensitivity may have an anaphylactoid reaction.
- VARIZIG contains less than 40 micrograms per milliliter of IgA.
Last reviewed on RxList: 2/19/2013
This monograph has been modified to include the generic and brand name in many instances.
Additional VariZIG Information
Report Problems to the Food and Drug Administration
Find out what women really need.